HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

LMB89 protocol

Subscribe to New Research on LMB89 protocol

chemotherapy protocol consisting of above cpds for the treatment of B-cell lymphomas and L3 leukemia

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Therapeutics: 15318
- Drug Therapy: 178671
  - Combination Drug Therapy: 9625
    - Antineoplastic Combined Chemotherapy Protocols: 23
      - LMB89 protocol: 4
  - Antineoplastic Protocols: 26
    - Antineoplastic Combined Chemotherapy Protocols: 23
      - LMB89 protocol: 4
- Clinical Protocols
  - Antineoplastic Protocols: 26
    - Antineoplastic Combined Chemotherapy Protocols: 23
      - LMB89 protocol: 4
Heterocyclic Compounds: 60
Enzymes and Coenzymes
- Coenzymes: 98
  - Tetrahydrofolates: 8
    - Formyltetrahydrofolates
      - Leucovorin: 4314
        LMB89 protocol: 4
Organic Chemicals: 58
- Hydrocarbons: 412
  - Halogenated Hydrocarbons: 31
    - Mustard Compounds: 2
      - Nitrogen Mustard Compounds: 1
        Phosphoramide Mustards: 4
        Cyclophosphamide: 18416
        LMB89 protocol: 4
  - Cyclic Hydrocarbons: 3
    - Aromatic Hydrocarbons: 132
      - Aromatic Polycyclic Hydrocarbons: 831
        Naphthalenes: 9
        Tetrahydronaphthalenes: 1
        Podophyllotoxin: 391
        Etoposide: 8030
        LMB89 protocol: 4
        Naphthacenes
        Anthracyclines: 2011
        Daunorubicin: 1964
        Doxorubicin: 20907
        LMB89 protocol: 4
- Organophosphorus Compounds: 163
  - Phosphoramide Mustards: 4
    - Cyclophosphamide: 18416
      - LMB89 protocol: 4
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 713
  - Pyrimidine Nucleosides: 41
    - Cytidine: 355
      - Cytarabine: 4912
        LMB89 protocol: 4
  - Arabinonucleosides
    - Cytarabine: 4912
      - LMB89 protocol: 4
Polycyclic Compounds: 56
- Steroids: 18537
  - Pregnanes: 3
    - Pregnadienes
      - Pregnadienediols
        Prednisone: 8946
        LMB89 protocol: 4
    - Pregnenes
      - Pregnenediones
        Hydrocortisone: 15970
        LMB89 protocol: 4
- Aromatic Polycyclic Hydrocarbons: 831
  - Naphthalenes: 9
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 391
        Etoposide: 8030
        LMB89 protocol: 4
  - Naphthacenes
    - Anthracyclines: 2011
      - Daunorubicin: 1964
        Doxorubicin: 20907
        LMB89 protocol: 4
Carbohydrates: 4088
- Glycosides: 547
  - Aminoglycosides: 1446
    - Anthracyclines: 2011
      - Daunorubicin: 1964
        Doxorubicin: 20907
        LMB89 protocol: 4
  - Glucosides: 155
    - Etoposide: 8030
      - LMB89 protocol: 4
Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 60571
  - Adrenal Cortex Hormones: 24317
    - Hydroxycorticosteroids: 7
      - 17-Hydroxycorticosteroids: 166
        Hydrocortisone: 15970
        LMB89 protocol: 4
      - 11-Hydroxycorticosteroids: 50
        Hydrocortisone: 15970
        LMB89 protocol: 4

Experts

1.	Patte, C: 2 articles (05/2002 - 06/2001)
2.	Société Française d'Oncologie Pédiatrique: 2 articles (05/2002 - 06/2001)
3.	Fernández-Delgado, Rafael: 1 article (05/2007)
4.	Pardo, Nuria: 1 article (05/2007)
5.	Navajas, Aurora: 1 article (05/2007)
6.	Indiano, José M: 1 article (05/2007)
7.	García-Miguel, Purificación: 1 article (05/2007)
8.	en representación del grupo SHOP de las Sociedades Españolas de Hematología (SEHP) y Oncología Pediátricas (SEOP): 1 article (05/2007)
9.	Estella, Jesús: 1 article (05/2007)
10.	Gallego, Soledad: 1 article (05/2007)

Related Diseases

1.	B-Cell Lymphoma (Lymphoma, B Cell) 05/05/2007 - "The results confirm the good efficiency of the LMB89 protocol for treating B-cell lymphoma and L3 leukemia, despite having diminished the treatment intensity in the less risk groups. " 05/01/2002 - "Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol." 06/01/2001 - "The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia."
2.	Leukemia 05/01/2002 - "Retrospective review of the clinical records of 410 patients with stage III and IV B-cell NHL and L3 leukemia treated in France and prospectively registered in the LMB89 protocol. " 05/05/2007 - "The results confirm the good efficiency of the LMB89 protocol for treating B-cell lymphoma and L3 leukemia, despite having diminished the treatment intensity in the less risk groups. " 05/01/2002 - "Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol." 06/01/2001 - "The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia."
3.	Neoplasms (Cancer) 06/01/2001 - "The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia."
4.	Burkitt Lymphoma (Burkitt's Lymphoma) 02/01/2005 - "We report our results in a serie of 95 children with Burkitt lymphoma treated between September 1990 and December 2000 according to SFOP LMB89 protocol. " 02/01/2005 - "[Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca]."

Related Drugs and Biologics

1.	Urate Oxidase (Uricase)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)